ym 529 has been researched along with formaldehyde in 2 studies
| Studies (ym 529) | Trials (ym 529) | Recent Studies (post-2010) (ym 529) | Studies (formaldehyde) | Trials (formaldehyde) | Recent Studies (post-2010) (formaldehyde) |
|---|---|---|---|---|---|
| 140 | 23 | 71 | 22,546 | 243 | 5,887 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakimoto, S; Mori, M; Nagakura, Y; Okada, M; Sasamata, M; Shibasaki, K; Tamura, S; Tanaka, S; Watabiki, T | 1 |
| Aonuma, H; Kasukawa, Y; Miyakoshi, N; Segawa, T; Shimada, Y; Tsuchie, H | 1 |
2 other study(ies) available for ym 529 and formaldehyde
| Article | Year |
|---|---|
Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X(2/3) receptor function and exerts an analgesic effect in pain models.
Topics: Acetic Acid; Adenosine Triphosphate; Analgesics, Non-Narcotic; Animals; Bone Density Conservation Agents; CHO Cells; Cricetinae; Cricetulus; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Imidazoles; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Pain; Pain Measurement; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Time Factors; Transfection | 2008 |
Analgesic effects of minodronate on formalin-induced acute inflammatory pain in rats.
Topics: Acute Pain; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Diphosphonates; Female; Formaldehyde; Imidazoles; Morphine; Nociception; Pain Measurement; Rats; Rats, Wistar | 2013 |